Problem:
Tissue biopsies are invasive & cannot be repeated. PET-CT has a limit of detection (>10 to 12 mm tumor size) and it is too late when detected.

Our Solution:
We have developed a microfluidics lab-on-a-chip liquid biopsy platform (2 ml blood sample) that is affordable, accessible, non-invasive, informative, timely and repeatable to help oncologists assess the treatment effectiveness, clinical outcomes & possibility of cancer recurrence